Patent ID: 8017628

Claim:
A method of treating a neuronal disorder, an autoimmune disease, or a cardiovascular disease in a patient in need of such treatment, the method comprising administering a therapeutically effective amount of a sulfonyl hydrazide compound according to formula I geometrical isomers thereof, optically active enantiomers thereof, diastereomers thereof, racemates thereof, and/or pharmaceutically acceptable salts thereof, wherein Ar 1 and Ar 2 are independently from each other an unsubstituted or substituted aryl or heteroaryl group, X 1 and X 2 are independently from each other O or S; R 1 , R 2 , R 3 are independently from each other hydrogen or a C 1 -C 6 -alkyl substituent or R 1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar 1 ; or R 2 and R 3 form a substituted or unsubstituted 5-6-membered saturated or un-saturated ring; n is an integer from 0 to 5; G is an unsubstituted or substituted 4-8 membered heterocycle containing at least one heteroatom, or G is a substituted or unsubstituted C 1 -C 6 -alkyl group.